FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to ophthalmic oncology, and can be used for diagnosing lachrymal cancer. Lachrymal fluid of both eyes is analysed for alpha-2-macroglobulin activity. If value is more than 7.0 nmol/min×ml in lachrymal both healthy and patient's eye is diagnosed with cancer of lachrymal gland.
EFFECT: method provides an opportunity to improve the non-invasive differential diagnosis of lachrymal gland cancer and the selection of a therapeutic approach in the pre- and postoperative period by determining the activity of alpha-2-macroglobulin in the lachrymal fluid of both eyes in patients with tumours of the lachrymal glands at the stage of preoperative preparation.
1 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR DETECTING AN ACTIVE DESTRUCTIVE PROCESS IN THE RETINA IN AN EXPERIMENT | 2021 |
|
RU2768588C1 |
| METHOD FOR EARLY DIAGNOSIS OF PARKINSON'S DISEASE | 2019 |
|
RU2722666C1 |
| METHOD FOR DETERMINING INDICATIONS FOR ACTIVE ANTI-INFLAMMATORY THERAPY BEFORE PERFORMING OPTO-RECONSTRUCTIVE OPERATIONS IN CHILDREN WITH ENDOGENOUS UVEITIS | 2022 |
|
RU2782132C1 |
| METHOD FOR DIAGNOSING PATHOLOGICAL CHANGES OF LACHRYMAL GLAND | 2024 |
|
RU2840377C1 |
| METHOD OF EXPERIMENTAL TREATMENT OF EYE NEURODEGENERATIVE PROCESS | 2023 |
|
RU2794835C1 |
| METHOD OF TREATING PATIENTS WITH "DRY EYE" SYNDROME | 2011 |
|
RU2463022C1 |
| METHOD OF TREATING DEFICIENCY IN BASAL LACHRYMAL SECRETION | 2008 |
|
RU2377965C1 |
| METHOD FOR PREDICTING CORNEAL SUBEPITHELIAL FIBROPLASIA DEVELOPMENT AFTER PHOTOREFRACTIVE EXCIMER LASER KERATECTOMY | 2005 |
|
RU2291429C1 |
| METHOD FOR ULTRASOUND EXAMINATION OF THE LACRIMAL GLAND | 2021 |
|
RU2759385C1 |
| METHOD FOR PREVENTING EROSION AND ULCERATION OF CORNEA IN THE CASES OF BILATERAL EYE BURNS | 2001 |
|
RU2198635C1 |
